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Abstract
Jean-Luc Darlix was recently recognized with the first Retrovirology Lifetime Achievement Award on the occasion of
his “retirement” symposium in Lyon.
On June 1-2, 2011, a special symposium was organized
at the Ecole Normale Superieure (ENS) in Lyon, France
to mark the imminent retirement from that institution
of its Head of Human Virology, Professor Jean-Luc Dar-
lix. The symposium featured scientific presentations by
both French and international scientists who came from
countries throughout the world to pay tribute to their
friend and colleague and to celebrate with him his
legendary and fulfilling career in virology and biochem-
istry that has spanned more than four decades. During
this time, Jean-Luc Darlix has been responsible for the
training of more than 50 graduate students and post-
doctoral fellows, many of whom are now outstanding
scientists in their own right and who hold independent
research positions both in France and elsewhere. The
occasion was marked by a special recognition given to
Jean-Luc by the Editors of Retrovirology. Notably, Pro-
fessor Darlix was a founding member of the editorial
board of Retrovirology and has served tirelessly on the
board for the past eight years. He has also authored ele-
ven Retrovirology papers including recent contributions
[1,2]. To honor his multiple and original achievements
over many years toward the advancement of retrovirus
research, Jean-Luc received the first ever Retrovirology
Lifetime Achievement Award (Figure 1).
Jean-Luc obtained his PhD under the supervision of P
Fromageot and F Gros while studying “In Vitro Tran-
scription of DNA by Using Purine Nucleotide Analogs”.
Subsequently, he performed post-doctoral research in
both the USA and in Switzerland, prior to taking up his
first faculty position in 1977 at the University of Geneva
where he studied both Rous Sarcoma virus(RSV) and
Moloney Leukemia virus (MLV) as models of viral repli-
cation. It was during this period that Jean-Luc published
some of the first findings anywhere on retroviral diver-
sity and this work infused him with the passion that
would define his career as someone who wanted to
understand the details of retroviral replication in a man-
ner that other scientists had never been able to accom-
plish. When HIV-1 was identified in 1983 as the
causative agent of AIDS, Jean-Luc was well placed to
take on the study of this latter virus.
In 1985, Jean-Luc moved back to France to take up an
independent faculty position in Toulouse, where he
broadened his work on RSV and MLV, before ultimately
turning much of his focus to the study of HIV. In 1990,
he accepted the position at ENS Lyon that he has occu-
pied to this time, all the while moving up the ranks at
the Ecole Normale Superieure through promotions and
the assumption of major administrative responsibilities.
Remarkably, Jean-Luc has maintained a track record of
outstanding scientific achievement throughout his career
with over 200 major publications in excellent peer-
reviewed journals. His work is among the most highly
cited of any retrovirologist in the world, and he is
responsible for a multitude of original scientific observa-
tions. Chief among these is his seminal work on the role
of the viral Nucleocapsid (NC) protein in the promotion
of retroviral reverse transcription and as a chaperone
protein that interacts with both viral nucleic acid as well
as other viral proteins. As such, Jean-Luc was the first
scientist to truly understand that NC played crucial
roles in both of the pre- as well as post-integrational
phases of the retroviral life cycle. This has given rise to
efforts to develop drugs that might antagonize the NC
protein, particularly that of HIV, and Jean-Luc, together
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with French and American colleagues, played a key role
in determining that the two Zinc finger motifs of NC
might represent the most likely avenue for anti-NC drug
development. These efforts continue today in labora-
tories throughout the world.
It is, however, fair to point out that Jean-Luc’s work
has also directly contributed to the development of the
nucleoside analog compounds that are today used to
treat HIV infections. His fundamental research over
many years on reverse transcription and viral diversity
helped to establish the techniques necessary to screen
antiretroviral drugs in both viral replication as well as in
cell-free reverse transcriptase reactions. And, his under-
standing of retroviral diversification also enabled Jean-
Luc to be one of the first to predict the limitations of
antiretroviral therapy and the emergence of HIV drug
resistance.
In addition to his role as a mentor to his own stu-
dents and post-doctoral fellows, Jean-Luc has also
been a wonderful colleague and friend to countless
numbers of scientists. His lab was always open to
junior scientists who were sent to Lyon to learn tech-
niques for assessing retroviral replication from the
members of Jean-Luc’s team. His published bibliogra-
phy shows a multitude of papers that he co-authored
with other scientists in the field. This provides further
testimony to his ability to befriend others as well as to
work in harmony through the sharing of laboratory
constructs and reagents. In addition, Jean-Luc served
over many years as a member of grants panels in
France through the Agence Nationale pour la
Recherche contre le SIDA (ANRS) and Sidaction, as
well as in the United States and Canada. His colleagues
at grants panel meetings will recollect that Jean-Luc
always went to extraordinary lengths to ensure that his
clothes were the most muti-colored and loud of any-
one on the committee, a dress code that sometimes
also carried over to the laboratory.
To this day, Jean-Luc remains passionate about scien-
tific discovery and feels a sense of excitement each time
one of his papers is published. Nothing gives him more
pleasure than discussing and even arguing about the
intricacies of retroviral replication with colleagues and
friends. But, Jean-Luc is also an exceptionally well-
rounded individual with other interests as well. Of
course, he remains devoted to his family and four chil-
dren and takes great pride in their accomplishments. In
addition, Jean-Luc is a noted gourmet who not only
enjoys and can provide excellent advice on fine cuisine,
but he is himself an experienced chef, who time permit-
ting, can turn out as fine a meal as any virologist in the
world. And, Jean-Luc is never afraid to turn back a bot-
tle of wine in a restaurant, if his uncanny sense of smell
and taste tells him that a bottle has “turned”.
But, of course, no tribute to Jean-Luc could be com-
plete without mentioning his accomplishments as a
mountaineer and climber who has scaled peaks in the
Alps, Rockies, Andes, and elsewhere, while of course
appropriately dressed to withstand cold and snow condi-
tions (Figure 2). Indeed, Jean-Luc holds advanced
degrees in mountaineering from schools in France, and
is also a teacher of mountaineering arts. Everyone who
knows Jean-Luc is familiar with the photographs that
have been taken of him at the tops of snow-capped
mountain peaks. It is remarkable how he found the time
to indulge his passion for climbing while maintaining
devotion to his laboratory as well as an outstanding
publication record.
No one who knows Jean-Luc believes that his scienti-
fic career will slow down anytime soon. Rather, it is
simply entering a new phase of collaborations and
potential industrial consulting that will continue to yield
important accomplishments and research publications
Figure 1 Presentation of the Retrovirology Lifetime
Achievement Award. (left) From left: Mark A. Wainberg, Ben
Berkhout (Editors), Jean-Luc Darlix (award recipient) and Kuan-Teh
Jeang (Editor-in-Chief). (right) Photograph of the Retrovirology
Lifetime Achievement Award trophy.
Figure 2 Photograph of Professor Jean-Luc Darlix in mountain
gear.
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for many years to come. A few of Jean-Luc’s favourite
papers are listed in the reference list below [3-10].
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